Entrepreneur Michael Arnolt teamed with an inventor more than 20 years ago to launch an enterprise that has sold thousands of steel therapy instruments and trained thousands of clinicians.
At issue in the five-year legal dispute was whether Dr. Rick Sasso was properly compensated for various inventions, and whether Minnesota-based Medtronic paid him sufficient royalties as spelled out in their agreements.
It’s the foundation’s first capital campaign since 2010, when it raised $200 million. The money will be used for pediatric research, patient care, maternity and newborn health, and family support programs.
Riverview Health plans to build one of its new freestanding combined ER/urgent care facilities on Hazel Dell Road, south of 146th Street.
A senior housing community east of the St. Vincent Hospital campus is expected to undergo a major expansion over the next year that will add several dozen independent-living residences.
New employees at Eli Lilly and Co. get a letter encouraging them to join one of the pharmaceutical firm’s affinity groups. There’s one for African Americans, one for Latino employees—and four for Asians.
Indiana State Police collected more than a ton of expired and unwanted prescription medications Oct. 27 as part of the national “Prescription Drug Take Back” initiative sponsored by the U.S. Drug Enforcement Administration.
The crisis has been years in the making, and the job of wrestling it to the ground has grown into a massive task. No one is yet predicting when the state will be able to declare victory.
FDA Commissioner Scott Gottlieb said the FDA wanted to issue a warning about a new E. coli outbreak before people gathered for Thanksgiving meals, where the potential for exposure could increase.
Jane Pauley Community Health Center plans to fill about a third of the space, which was vacated by defunct grocery chain Marsh Supermarkets in May 2017.
Regulators say additional products from other companies could be named as their investigation continues.
Indianapolis-based Lilly is working with advisers to gauge interest in selling off a selection of older drugs for antibiotics and central nervous system diseases in China.
The researchers are testing the effectiveness of a small, targeted molecule to prevent or reverse chemotherapy-induced peripheral neuropathy—a nerve problem that causes pain, numbness and tingling.
New limitations will be placed on e-cigarettes, according to a senior FDA official, restricting sales of many popular fruit flavors amid what the health agency has called an epidemic of youth use.
Lilly’s revenue in the United States rose 11 percent year-over-year, to $3.4 billion, thanks largely to rising sales of diabetes drugs Trulicity and Basgalar, cancer treatment Verzenio and psoriasis medication Taltz.
Executives and directors of the West Lafayette-based biotech hold nearly 9 percent of Endocyte stock, worth about $177 million, based on the deal price of $24 a share.
For at least a year, county officials have debated how best to pay for the county’s 911 communications operation going forward.
Look at the future prospects, not the losses, says the CEO of a newly listed Chinese biotech company that’s developing anti-cancer drugs with Indianapolis-based Eli Lilly and Co.
On average, the premium for typical plans in the 39 states that use the federal healthcare.gov website will drop 1.5 percent.
Two reports, sponsored by the Richard M. Fairbanks Foundation, say the state should not let up in fighting twin scourges that claim thousands of lives and cost billions of dollars in health care costs and lost productivity.
